LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Nov 1, 2024 | (Q2)Aug 2, 2024 | (Q1)May 3, 2024 | (FY)Feb 2, 2024 | (Q4)Feb 2, 2024 | (Q3)Nov 3, 2023 | (Q2)Aug 4, 2023 | (Q1)May 5, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -47.89%4.52B | -61.84%585M | -27.83%1.55B | -58.31%1.34B | -41.31%1.04B | 143.37%8.68B | -43.52%1.53B | 443.43%2.15B | 343.92%3.21B | 1.78B |
Net income from continuing operations | 43.22%4.58B | 32.30%1.53B | 12.25%1.13B | 84.84%841M | 65.22%955M | 31.92%3.2B | 91.09%1.16B | 316.60%1B | -10.08%455M | --578M |
Depreciation and amortization | ---- | ---- | -6.93%765M | -5.66%784M | -1.11%800M | 4.66%3.3B | -1.52%841M | -1.20%822M | 11.69%831M | --809M |
Deferred tax | ---- | ---- | -56.00%-78M | 83.17%-17M | -251.61%-327M | 87.31%-91M | 446.43%153M | 86.23%-50M | 25.74%-101M | ---93M |
Other non cash items | -109.03%-55M | -1,176.14%-947M | 300.00%164M | 35.47%233M | -27.27%224M | -36.63%609M | -71.88%88M | -79.40%41M | -68.15%172M | --308M |
Change In working capital | ---- | ---- | -676.85%-623M | -142.35%-692M | -1,538.00%-819M | 124.53%782M | -232.85%-910M | 114.44%108M | 240.14%1.63B | ---50M |
-Change in receivables | ---- | ---- | -63.51%405M | -122.64%-3.37B | -84.62%518M | 1,044.25%3.29B | 137.46%324M | -18.68%1.11B | 23.95%-1.52B | --3.37B |
-Change in inventory | ---- | ---- | -626.14%-805M | -450.00%-1.28B | -280.70%-1.24B | 11.43%975M | -116.76%-228M | 141.13%153M | 19.61%366M | --684M |
-Change in payables and accrued expense | ---- | ---- | -71.57%-712M | 65.35%3.56B | 270.94%1.24B | 96.08%-335M | 66.99%-1.35B | 85.00%-415M | 1,181.91%2.15B | ---726M |
-Change in other working capital | ---- | ---- | 166.08%489M | -36.19%402M | 60.24%-1.34B | -165.08%-3.14B | -92.01%341M | -172.20%-740M | -12.38%630M | ---3.38B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -47.89%4.52B | -61.84%585M | -27.83%1.55B | -58.31%1.34B | -41.31%1.04B | 143.37%8.68B | -43.52%1.53B | 443.43%2.15B | 343.92%3.21B | --1.78B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 20.41%-2.22B | -1.35%-678M | 36.48%-524M | 7.93%-557M | 33.33%-456M | 7.97%-2.78B | 15.95%-669M | -13.01%-825M | 22.24%-605M | -684M |
Capital expenditure reported | 3.77%-2.65B | -1.10%-735M | 9.23%-639M | -9.29%-682M | 14.98%-596M | 8.23%-2.76B | 4.22%-727M | 5.76%-704M | 22.68%-624M | ---701M |
Net business purchase and sale | --0 | --0 | ---- | ---- | ---- | -80.00%-126M | 101.43%1M | ---- | ---- | ---- |
Net investment purchase and sale | 375.93%257M | -93.62%3M | 1,557.14%102M | 620.00%72M | 1,900.00%80M | 575.00%54M | 370.00%47M | -170.00%-7M | -54.55%10M | --4M |
Net other investing changes | 300.00%180M | 440.00%54M | 0.00%13M | 488.89%53M | 361.54%60M | 9.76%45M | -56.52%10M | 85.71%13M | 28.57%9M | --13M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 20.41%-2.22B | -1.35%-678M | 36.48%-524M | 7.93%-557M | 33.33%-456M | 7.97%-2.78B | 15.95%-669M | -13.01%-825M | 22.24%-605M | ---684M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 18.03%-5.82B | 23.53%-1.39B | 78.22%-315M | -11.22%-2.03B | -3.75%-2.08B | -336.55%-7.09B | -220.22%-1.82B | -274.61%-1.45B | -74.67%-1.83B | -2B |
Net issuance payments of debt | 62.20%-1.31B | 45.65%-331M | 210.34%480M | 21.92%-976M | 58.79%-485M | -230.78%-3.47B | -131.17%-609M | -191.19%-435M | -1,057.41%-1.25B | ---1.18B |
Net common stock issuance | -29.57%-3.16B | 16.00%-751M | 38.65%-454M | -179.55%-738M | -124.45%-1.22B | 25.46%-2.44B | -388.52%-894M | -18.97%-740M | 61.68%-264M | ---544M |
Cash dividends paid | -18.94%-1.28B | -19.16%-311M | -17.29%-312M | -17.47%-316M | -21.74%-336M | -11.20%-1.07B | -10.59%-261M | -11.76%-266M | -11.16%-269M | ---276M |
Net other financing activities | 41.28%-64M | 103.64%2M | -480.00%-29M | 95.45%-2M | -600.00%-35M | -179.49%-109M | -150.00%-55M | -66.67%-5M | -528.57%-44M | ---5M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 18.03%-5.82B | 23.53%-1.39B | 78.22%-315M | -11.22%-2.03B | -3.75%-2.08B | -336.55%-7.09B | -220.22%-1.82B | -274.61%-1.45B | -74.67%-1.83B | ---2B |
Net cash flow | ||||||||||
Beginning cash position | -15.59%7.51B | -36.03%5.4B | -46.00%4.67B | -24.79%5.96B | -15.59%7.51B | -11.78%8.89B | 61.72%8.45B | 41.97%8.65B | 8.95%7.93B | --8.89B |
Current changes in cash | -192.17%-3.51B | -55.39%-1.48B | 700.00%714M | -259.72%-1.25B | -63.92%-1.49B | -10.79%-1.2B | -127.83%-955M | 83.47%-119M | 171.09%782M | ---909M |
Effect of exchange rate changes | 3.76%-179M | -821.43%-101M | 122.89%19M | 28.81%-42M | 5.17%-55M | -78.85%-186M | -94.14%14M | 44.30%-83M | 28.92%-59M | ---58M |
End cash Position | -49.13%3.82B | -49.13%3.82B | -36.03%5.4B | -46.00%4.67B | -24.79%5.96B | -15.59%7.51B | -15.59%7.51B | 61.72%8.45B | 41.97%8.65B | --7.93B |
Free cash flow | -68.43%1.87B | -118.61%-150M | -36.88%914M | -74.59%658M | -58.46%447M | 953.38%5.92B | -58.77%806M | 512.54%1.45B | 3,220.48%2.59B | --1.08B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |